Literature DB >> 1703778

Use of a centromere-specific DNA probe (p82H) in nonisotopic in situ hybridization for classification of micronuclei.

P Becker1, H Scherthan, H Zankl.   

Abstract

The DNA probe p82H was used to visualize centromeric DNA in micronuclei (MN) of human cells. Slides prepared from cultures treated by the aneugen (causing aneuploidy) colcemid showed significantly more MN with centromeric signals than those treated by the clastogen (causing chromosome breakage) bleomycin. These results indicate that in situ hybridization with the alphoid p82H DNA probe is a suitable method with which to distinguish between MN containing whole chromosomes and acentric fragments, and hence allows one to discriminate between the clastogenic and aneugenic effects in MN formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703778     DOI: 10.1002/gcc.2870020111

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Cytokinesis Blocked Micronuclei Aberration Analysis.

Authors:  Takamitsu A Kato
Journal:  Methods Mol Biol       Date:  2023

2.  Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity.

Authors:  D D Von Hoff; J R McGill; B J Forseth; K K Davidson; T P Bradley; D R Van Devanter; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  Aneuploidy and ageing: sex chromosome exclusion into micronuclei.

Authors:  M Guttenbach; R Schakowski; M Schmid
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

4.  FISH analysis on spontaneously arising micronuclei in the ICF syndrome.

Authors:  M Stacey; M S Bennett; M Hulten
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

Review 5.  Micronucleus assay in lymphocytes as a tool to biomonitor human exposure to aneuploidogens and clastogens.

Authors:  H Norppa; S Luomahaara; H Heikanen; S Roth; M Sorsa; L Renzi; C Lindholm
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.